Hummmmmm,,,,,,,,,,,,in regards to new drug pricing and 208 being very expensive if it ever gets FDA approval,,,the following has been told to us by RVX!

1)  Hasn't RVX Management calculated 208 to cost $4 - $6000 per year per patient!

2) Did RVX not state that when the medical system was poled the concensus was if 208 met its intent that it would be prescribed as SoC!

3) In addition, hasn't the health insurance companies also agreed that 208 would be sought after to replace the present standard of care that can be in excess of $100,000 per year per patient! (Health insurers undoubtedly sit in wait rubbing their mits together in hope that 208 gets approved!!).

My memory tells me that all the above comments came directly from our Management team.